Liang Peng Selected Research

Brain Edema (Cerebral Edema)

3/2017	Multifactorial Effects on Different Types of Brain Cells Contribute to Ammonia Toxicity.
12/2015	Role of the Astrocytic Na(+), K(+)-ATPase in K(+) Homeostasis in Brain: K(+) Uptake, Signaling Pathways and Substrate Utilization.
2/2015	Ammonia, like K(+), stimulates the Na(+), K(+), 2 Cl(-) cotransporter NKCC1 and the Na(+),K(+)-ATPase and interacts with endogenous ouabain in astrocytes.
1/2014	Inhibition of brain swelling after ischemia-reperfusion by β-adrenergic antagonists: correlation with increased K+ and decreased Ca2+ concentrations in extracellular fluid.
11/2013	Ammonia-induced Na,K-ATPase/ouabain-mediated EGF receptor transactivation, MAPK/ERK and PI3K/AKT signaling and ROS formation cause astrocyte swelling.
6/2012	Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined.
6/2011	Astrocyte ERK phosphorylation precedes K(+)-induced swelling but follows hypotonicity-induced swelling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liang Peng Research Topics

Disease

63	Neoplasms (Cancer) 04/2024 - 01/2008
28	Inflammation (Inflammations) 03/2024 - 01/2013
21	Infections 01/2024 - 04/2012
18	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2008
15	Hepatitis B 08/2023 - 08/2004
14	Non-alcoholic Fatty Liver Disease 12/2023 - 01/2016
13	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 09/2009
13	Chronic Hepatitis B 11/2023 - 09/2011
12	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 06/2011
11	Body Weight (Weight, Body) 04/2024 - 02/2017
11	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 03/2015
11	Acute-On-Chronic Liver Failure 08/2023 - 11/2013
10	Nasopharyngeal Carcinoma 01/2020 - 01/2018
9	Insulin Resistance 01/2022 - 01/2014
8	Type 2 Diabetes Mellitus (MODY) 04/2024 - 01/2012
8	Fibrosis (Cirrhosis) 11/2023 - 09/2011
8	Obesity 10/2023 - 01/2013
8	Hepatic Encephalopathy 01/2022 - 04/2012
7	Squamous Cell Carcinoma of Head and Neck 04/2024 - 01/2020
7	End Stage Liver Disease 01/2023 - 09/2011
7	Liver Diseases (Liver Disease) 01/2022 - 11/2006
7	Carcinogenesis 10/2020 - 01/2010
7	Brain Edema (Cerebral Edema) 03/2017 - 06/2011
6	Colitis 01/2023 - 08/2015
6	Ischemia 04/2022 - 07/2003
6	Dysbiosis 01/2022 - 01/2020
6	Carcinoma (Carcinomatosis) 01/2015 - 01/2008
4	Kidney Diseases (Kidney Disease) 02/2024 - 01/2023
4	Neuroblastoma 03/2023 - 08/2020
4	Myocardial Infarction 01/2023 - 01/2015
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2011
4	Meningitis 01/2022 - 01/2015
4	COVID-19 09/2021 - 01/2020
4	Sepsis (Septicemia) 01/2020 - 08/2010
4	Acute Liver Failure (Fulminant Hepatic Failure) 03/2017 - 01/2012
4	Anhedonia 08/2015 - 11/2012
4	Bipolar Disorder (Manic Depressive Psychosis) 05/2015 - 10/2008
4	Liver Failure 11/2014 - 09/2011
3	Oropharyngeal Neoplasms 03/2024 - 01/2022
3	IGA Glomerulonephritis (IGA Nephropathy) 12/2023 - 01/2020
3	Mitochondrial Diseases (Mitochondrial Disease) 09/2023 - 06/2014
3	Stomach Neoplasms (Stomach Cancer) 09/2023 - 01/2015
3	Ulcerative Colitis 01/2023 - 03/2019
3	Wounds and Injuries (Trauma) 11/2022 - 01/2018
3	Reperfusion Injury 04/2022 - 12/2010
3	Hypoxia (Hypoxemia) 04/2022 - 12/2010

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2009
17	Biomarkers (Surrogate Marker)IBA 04/2024 - 09/2009
11	LipidsIBA 12/2023 - 01/2017
11	BilirubinIBA 08/2023 - 09/2011
10	Therapeutic UsesIBA 12/2023 - 10/2008
9	RNA (Ribonucleic Acid)IBA 09/2023 - 01/2020
9	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 11/2006
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2015
7	AlbuminsIBA 09/2023 - 09/2011
7	Insulin (Novolin)FDA Link 01/2023 - 01/2014
6	Messenger RNA (mRNA)IBA 10/2023 - 12/2011
6	PrebioticsIBA 01/2023 - 01/2020
6	Adenosine Triphosphatases (ATPase)IBA 03/2017 - 04/2013
6	Fluoxetine (Prozac)FDA LinkGeneric 08/2015 - 09/2009
5	MicroRNAs (MicroRNA)IBA 05/2024 - 07/2010
5	4-toluenesulfonyl fluoride (TSF)IBA 01/2024 - 01/2018
5	tangshenIBA 01/2024 - 01/2018
5	Hepatitis B e AntigensIBA 11/2023 - 11/2006
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2023 - 08/2021
5	C-Reactive ProteinIBA 09/2023 - 11/2013
5	Urea (Carbamide)FDA LinkGeneric 08/2023 - 01/2018
5	CytokinesIBA 11/2022 - 01/2012
5	CateninsIBA 01/2022 - 01/2018
5	EnzymesIBA 01/2021 - 08/2004
5	Prothrombin (Factor II)IBA 01/2021 - 04/2012
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2013
4	Histone Deacetylases (Histone Deacetylase)IBA 03/2024 - 11/2022
4	NitrogenIBA 08/2023 - 08/2021
4	Alanine Transaminase (SGPT)IBA 08/2023 - 09/2011
4	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 01/2017
4	InterferonsIBA 10/2022 - 06/2012
4	AntigensIBA 03/2022 - 01/2019
4	CreatinineIBA 01/2022 - 04/2012
4	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2018
4	Antidepressive Agents (Antidepressants)IBA 08/2018 - 09/2009
4	Cadherins (E-Cadherin)IBA 04/2018 - 10/2009
4	ErbB Receptors (EGF Receptor)IBA 01/2018 - 11/2013
4	AmmoniaIBA 03/2017 - 06/2012
4	Glutamic Acid (Glutamate)FDA Link 01/2016 - 02/2012
3	Monoclonal AntibodiesIBA 10/2023 - 01/2018
3	Transcription Factor 7-Like 2 ProteinIBA 06/2023 - 11/2019
3	Transcription Factors (Transcription Factor)IBA 05/2023 - 01/2015
3	Toll-Like Receptor 4IBA 01/2023 - 01/2021
3	Complement System Proteins (Complement)IBA 11/2022 - 01/2016
3	Peptides (Polypeptides)IBA 01/2022 - 05/2011

Therapy/Procedure

32	Therapeutics 04/2024 - 05/2006
8	Radiotherapy 03/2024 - 01/2018
6	Immunotherapy 04/2024 - 01/2019
5	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2024 - 11/2018
4	Induction Chemotherapy 01/2024 - 11/2018
4	Transplantation 08/2021 - 09/2011
3	Plasma Exchange 08/2023 - 01/2019
3	Drug Therapy (Chemotherapy) 01/2023 - 02/2018
3	Fecal Microbiota Transplantation 01/2022 - 01/2020